Dinsmore Christopher 4
4 · Kronos Bio, Inc. · Filed Oct 4, 2021
Insider Transaction Report
Form 4
Kronos Bio, Inc.KRON
Dinsmore Christopher
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2021-10-04$3.27/sh+9,189$30,048→ 105,549 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2021-10-04−9,189→ 315,308 totalExercise: $3.27Exp: 2030-06-14→ Common Stock (9,189 underlying) - Sale
Common Stock
2021-10-04$20.81/sh−9,189$191,195→ 96,360 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 17, 2021.
- [F2]The weighted average sale price for the transaction reported was $20.8069, and the range of prices were between $20.51 and $21.20. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F3]Immediately exercisable.